Xvivo Perfusion (XVIVO.ST) traded down -7.79 % during a 24 hours period ending at 03:02 AM Central Europe on Tuesday 27th. One Xvivo Perfusion stock can currently be bought for about SEK 202.2 on popular exchanges. Current supply of Xvivo Perfusion stocks is 31.5 mn. Xvivo Perfusion has a current market capitalization of SEK 6.5 bn and approximately SEK 35.2 mn worth of Xvivo Perfusion was traded on exchanges in the last 24 hours. Since last month end, Xvivo Perfusion has traded -13.45 % down. Simple moving average of last 200 days is at SEK 244.02. The highest price of past 52 weeks was recorded at SEK 314.8 on 08/11/2026. 52 weeks low was at SEK 160.1 on 11/18/2025.
Here is how related stocks have performed in the past 24 hours:
Hemnet (HEM.ST) traded down -6.95 % and now trades at SEK 73.4. Hemnet has a market capitalisation of SEK 6.8 bn. Current price/earnings ratio for Hemnet is 17.42.
Dometic (DOM.ST) traded up 1.98 % and now trades at SEK 20. Current market capitalisation for Dometic is SEK 6.6 bn.
Vbg -B (VBG-B.ST) traded down -0.81 % and now trades at SEK 312. Current market capitalisation for Vbg -B is SEK 7.7 bn. Current price/earnings ratio for Vbg -B is 18.61.
Bergman & Beving Aktiebolag (BERG-B.ST) traded up 0.19 % and now trades at SEK 256. Bergman & Beving Aktiebolag has a market capitalisation of SEK 7 bn. Current price/earnings ratio for Bergman & Beving Aktiebolag is 26.19.
Sivers Semiconductors (SIVE.ST) traded down -3.91 % and now trades at SEK 21.04. Sivers Semiconductors has a market capitalisation of SEK 6.6 bn.
About Xvivo Perfusion
Xvivo Perfusion AB is a medical technology company based in Goteborg, Sweden, that specializes in developing optimized solutions for organ, tissue, and cell preservation in connection with transplantation. These solutions are aimed at revolutionizing the current standard of care in the health care industry by providing innovative equipment and supplies for improved patient outcomes.